Advances in mesenchymal stromal cell therapy in the management of Crohn's disease

Expert Review of Gastroenterology & Hepatology
Hajir IbraheimNick Powell

Abstract

The aim of therapy in Crohn's disease (CD) is induction and maintenance of remission, promotion of mucosal healing and restoration of quality of life. Even the best treatment regimes, including combinations of biologics and immunomodulators lack durable efficacy and have well documented side effects. Accordingly, there is an unmet need for novel therapies. Mesenchymal stromal cells (MSCs) are a subset of non-hematopoietic stem cells that home to sites of inflammation where they exert potent immunomodulatory effects and contribute to tissue repair. Their utility is being explored in several inflammatory and immune mediated disorders including CD, where they have demonstrated favourable safety, feasibility and efficacy profiles. Areas covered: This review highlights current knowledge on MSC therapy and critically evaluates their safety, efficacy and potential mechanisms of action in CD. Expert commentary: Building on positive early phase clinical trials and a recent phase 3 trial in perianal CD, there is considerable optimism for the possibility of MSCs changing the treatment landscape in complicated CD. Although important questions remain unanswered, including the safety and durability of MSC therapy, optimal adjunctive therapie...Continue Reading

References

Mar 23, 2002·Gastroenterology·David A SchwartzWilliam J Sandborn
May 21, 2003·International Journal of Colorectal Disease·Damian García-OlmoLuis García-Sancho
Oct 11, 2003·Experimental Hematology·Katarina Le BlancOlle Ringdén
May 26, 2004·Best Practice & Research. Clinical Gastroenterology·R K Russell, J Satsangi
Oct 12, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Bruce E SandsUNKNOWN ACCENT II Study
Jun 4, 2005·Diseases of the Colon and Rectum·Damián García-OlmoJosé Antonio Rodríguez-Montes
Jul 14, 2005·Gastroenterology·Ailsa L HartAndrew J Stagg
Jul 29, 2005·Leukemia·J PlumasM-C Favrot
Sep 6, 2005·Blood·Anna CorcioneAntonio Uccelli
Aug 8, 2007·Gastroenterology·Kathrine Frey FrøslieUNKNOWN IBSEN Group
May 13, 2008·Lancet·Katarina Le BlancUNKNOWN Developmental Committee of the European Group for Blood and Marrow Transplantation
Aug 13, 2008·International Journal of Colorectal Disease·Damian Garcia-OlmoMariano Garcia-Arranz
Mar 7, 2009·Cell Stem Cell·Jeffrey M Karp, Grace Sock Leng Teo
Mar 11, 2009·Diseases of the Colon and Rectum·Damian Garcia-OlmoMaria Pascual
Apr 2, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Darwin J Prockop
Apr 3, 2009·Inflammatory Bowel Diseases·Fabian SchnitzlerPaul Rutgeerts
Apr 16, 2010·The New England Journal of Medicine·Jean Frédéric ColombelUNKNOWN SONIC Study Group
May 18, 2010·Experimental Cell Research·Anne M Hocking, Nicole S Gibran
Jul 28, 2010·Annals of Neurology·Peter J DarlingtonAmit Bar-Or
May 3, 2011·Gastroenterology·Jacques CosnesAntoine Cortot

❮ Previous
Next ❯

Citations

Dec 6, 2018·Current Stem Cell Research & Therapy·Alessandro Poggi, Maria R Zocchi
Jul 18, 2018·Stem Cells International·Mengyuan WangLiang Xie
Jun 2, 2020·Journal of Veterinary Science·Min Hee Kang, Hee Myung Park
Apr 17, 2020·Frontiers in Bioengineering and Biotechnology·Þóra SigmarsdóttirÓlafur E Sigurjónsson
May 2, 2019·Frontiers in Immunology·Noymar Luque-CamposPatricia Luz-Crawford
Jun 2, 2018·Obstetrics and Gynecology International·Kemal BeksacMehmet Sinan Beksac

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.